Horphag Research Nutrition will focus on function food and beverage development with Pycnogenol.
Following global market success with Pycnogenol dietary supplements, Horphag Research (Geneva) is launching a nutrition program for food and beverage development with the French maritime pine bark extract.
Horphag Research Nutrition will be headed by company vice president of sales and business development Markus Beba and vice president of technical development David Johnston. The program’s initial focus will be on women’s health and sports nutrition.
“Considerable expertise has been gained on taste and stability of Pycnogenol in complex formulations such as shakes, functional drinks, and fermented/non fermented dairy products…” said the company, adding that other applications for the ingredient include bars, margarine, and chewing gums.
Horphag is the exclusive world supplier of Pycnogenol, which is reportedly available as a food, beverage or dietary ingredient in over 80 countries. Pycnogenol carries U.S. Generally Recognized as Safe (GRAS) status and is kosher-certified. The ingredient is backed by clinical science in areas including joint health, cardiovascular health, and women’s health.
Nutritional Outlook's Women in Nutraceuticals Roundtable: The Future of Women's Health Research
July 19th 2024Watch "The Future of Women's Health Research," a roundtable discussion presented by Nutritional Outlook in partnership with Women in Nutraceuticals. This roundtable is supplement to a recent article commissioned by WIN and published by Nutritional Outlook, titled “Taking Initiative: Can the WHI’s model help the nutraceutical industry answer questions the study didn’t even ask?”
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.